MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Epidemiology of late-onset Parkinson’s disease in least-developed to Upper Middle-Income Countries: A Systematic Review and Meta-analysis

    G. Pereira, N. Soares, D. Teixeira-Dos-Santos, G. Marconi, D. Friedrich, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To conduct a meta-analysis of the epidemiological studies of Parkinson's disease (PD) performed in populations from least-developed to upper-middle-income countries. Background: While several epidemiology…
  • 2023 International Congress

    Safety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa/levodopa-treated patients with Parkinson’s disease: A phase 2a, double-blind, placebo-controlled study

    J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)

    Objective: To assess the safety, tolerability, and pharmacokinetics (PK) of NE3107 in carbidopa/levodopa (C/L)-treated patients with Parkinson’s disease (PD) Background: Disease-modifying therapies that augment the…
  • 2023 International Congress

    Serum levels of IL-1β and interleukin 6 in Parkinson’s disease

    S. Fezai, M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj (Tunis, Tunisia)

    Objective: We aim to assess IL-1 β and IL-6 serum levels in patients with PD and in controls and to explore their associations with clinical…
  • 2023 International Congress

    Linking volume of tissue activated to neural oscillations in deep brain stimulation

    A. Kutuzova, C. Graef, B. Lonergan, Y. Tai, S. Haar (London, United Kingdom)

    Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…
  • 2023 International Congress

    At-home adaptive deep brain stimulation improves motor fluctuations and quality of life in patients with Parkinson’s disease: a single-blind randomized study

    C. Oehrn, S. Cernera, L. Hammer, M. Shcherbakova, J. Yao, A. Hahn, C. Smyth, S. Little, P. Starr (San Francisco, USA)

    Objective: We evaluated the effect of at-home adaptive deep brain stimulation (aDBS) based on personalized neural biomarkers on motor symptoms and quality of life (QoL)…
  • 2023 International Congress

    self-compassion, trait worry and sleep in parkinson’s disease (PD) patients

    M. Cusnir, S. Diaconu, E. Ungureanu, B. Ciopleiasb, R. Zosin, I. Murasan, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to evaluate possible interactions between measures ofself-compassion, trait worry and sleep in Parkinson’s Disease (PD) patients. Background: PD patients often experience states of persistent…
  • 2023 International Congress

    p.Gln257Profs*27 mutation in progranulin gene in a patient with corticobasal syndrome – the importance of family history

    S. Marques, A. Ferreira, M. Lopes, R. Maré, M. Rodrigues (Braga, Portugal)

    Objective: To report a case of a family with a mutation in progranulin gene manifesting as corticobasal syndrome, frontotemporal dementia and parkinson's disease. Background: Corticobasal syndrome (CBS) is mostly…
  • 2023 International Congress

    Sport based approach in patients with Parkinson’s disease

    G. Peker (CABA, Argentina)

    Objective: We describe our 2-year experience implementing a sport based approach in patients with Parkinson’s Disease (PD). Background: PD is a progressive neurological disorder. The…
  • 2023 International Congress

    Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

    J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

    Objective: To describe the ongoing implementation and expansion of a telehealth psychotherapy hub to treat depression in rural Veterans with PD. Background: Depression is common…
  • 2023 International Congress

    Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

    EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

    Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 208
  • 209
  • 210
  • 211
  • 212
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley